Status:
SUSPENDED
Exercise Training to Improve Cardiopulmonary Hemodynamics in Heart Failure Patients
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
Florida Heart Research Institute
Conditions:
Heart Failure
Pulmonary Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research study is being done to find out if exercise therapy can help improve the heart function, overall health, and quality of life of patients with pulmonary hypertension caused by heart failu...
Detailed Description
The purpose of this research is to see if taking part in structured exercise training will improve the ability to exercise, the function of the heart, and the function of the blood vessels that supply...
Eligibility Criteria
Inclusion
- NYHA functional class I-IIIb.
- LVEF \< 40%.
- Clinically-stable for \> 3 months \[no change in disease status or medication\].
- Willing and able to provide written informed consent and perform cycle-ergometer or treadmill based exercise.
Exclusion
- NYHA class IV HF.
- Diagnosis of diastolic HF.
- Comorbidities such as obesity (BMI \>36), uncontrolled systemic hypertension, type 2 diabetes, and COPD (FEV1 \<50%).
- Musculoskeletal or other conditions that would limit exercise participation.
- Pregnant or nursing women
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04909008
Start Date
January 1 2024
End Date
December 1 2026
Last Update
April 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224